Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Herrlinger

Showing results (81-90 of 243) with videos related to

Pageof 25
Sort By:
Journal of Neuro-Oncology|December 9, 2021
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannomaJohannes Wach, Ági Güresir, Valeri Borger, et al.
Journal of Neuro-Oncology|February 8, 2021
Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resectionValeri Borger, Motaz Hamed, Inja Ilic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS LymphomaAgnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, et al.
Molecular Oncology|April 3, 2024
The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumoursMatthias Schneider, Anna-Laura Potthoff, Georg Karpel-Massler, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomideMarkus Weiler, Christian Hartmann, Dorothee Wiewrodt, et al.
Histology and Histopathology|April 29, 2025
Histological and molecular characterization of endolymphatic sac tumor reveals key differences from its primary differential diagnosis, choroid plexus papillomaLea L Friker, Rebecca Klein, Ralf Clauberg, et al.
Journal of Neuro-Oncology|January 25, 2023
Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic diseaseAnna-Laura Potthoff, Muriel Heimann, Felix Lehmann, et al.
Neurology|March 30, 2022
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With GliomaPia S Zeiner, Katharina Filipski, Natalie Filmann, et al.
Journal of Neuro-Oncology|February 8, 2014
Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment optionMaya Flieger, Ute Ganswindt, Silke Birgit Schwarz, et al.
Journal of Neuro-Oncology|September 6, 2019
Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resectionMatthias Schneider, Anna-Laura Potthoff, Vera C Keil, et al.
Pageof 25

Showing results (81-90 of 243) with videos related to

Sort By:
Pageof 25
Journal of Neuro-Oncology|December 9, 2021
Elevated baseline C-reactive protein levels predict poor progression-free survival in sporadic vestibular schwannomaJohannes Wach, Ági Güresir, Valeri Borger, et al.
Journal of Neuro-Oncology|February 8, 2021
Seizure outcome in temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resectionValeri Borger, Motaz Hamed, Inja Ilic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS LymphomaAgnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, et al.
Molecular Oncology|April 3, 2024
The Alcatraz-Strategy: a roadmap to break the connectivity barrier in malignant brain tumoursMatthias Schneider, Anna-Laura Potthoff, Georg Karpel-Massler, et al.
International Journal of Radiation Oncology, Biology, Physics|October 20, 2009
Chemoradiotherapy of newly diagnosed glioblastoma with intensified temozolomideMarkus Weiler, Christian Hartmann, Dorothee Wiewrodt, et al.
Histology and Histopathology|April 29, 2025
Histological and molecular characterization of endolymphatic sac tumor reveals key differences from its primary differential diagnosis, choroid plexus papillomaLea L Friker, Rebecca Klein, Ralf Clauberg, et al.
Journal of Neuro-Oncology|January 25, 2023
Survival after resection of brain metastasis: impact of synchronous versus metachronous metastatic diseaseAnna-Laura Potthoff, Muriel Heimann, Felix Lehmann, et al.
Neurology|March 30, 2022
Sex-Dependent Analysis of Temozolomide-Induced Myelosuppression and Effects on Survival in a Large Real-life Cohort of Patients With GliomaPia S Zeiner, Katharina Filipski, Natalie Filmann, et al.
Journal of Neuro-Oncology|February 8, 2014
Re-irradiation and bevacizumab in recurrent high-grade glioma: an effective treatment optionMaya Flieger, Ute Ganswindt, Silke Birgit Schwarz, et al.
Journal of Neuro-Oncology|September 6, 2019
Surgery for temporal glioblastoma: lobectomy outranks oncosurgical-based gross-total resectionMatthias Schneider, Anna-Laura Potthoff, Vera C Keil, et al.
Pageof 25